Seer
Seer Q3 Revenues up 5 Percent
The Redwood City, California-based proteomics firm posted revenues of $4.2 million, up from $4.0 million in the year-ago period.
GenomeWeb Top 40 Down 3 Percent in August, Tracking Broader Market
The Dow Jones Industrial Average was down 2 percent, while the Nasdaq was down 2 percent, and the Nasdaq Biotech Index was down less than 1 percent.
Seer Q2 Revenues up 11 Percent; Firm Cuts 2023 Guidance by Roughly a Third
The proteomics firm posted revenues of $4.0 million, up from $3.6 million in the year-ago period and below the consensus Wall Street estimate of $5.1 million.
Significant recent improvements in depth of coverage and throughput have substantial implications for both researchers and companies in the space.
In Brief This Week: HTG Molecular, Prenetics, DiaSorin, DermTech, NanoString Technologies, More
News items for the week of June 5, 2023
Jun 6, 2023
May 26, 2023
May 9, 2023
Seer Q1 Revenues Grow 22 Percent
Aug 11, 2022
JP Morgan Downgrades Seer to Neutral
Aug 10, 2022
Mar 25, 2022
Mar 15, 2022
PrognomiQ Closes $46M Financing Round
Feb 28, 2022